rationale impaired endothelial vasodilation inflammation apoptosis proliferation manifestations endothelial dysfunction chronic obstructive pulmonary disease copd prostacyclin pgi2 major product cyclooxygenase pathway potent vasodilatory antimitogenic properties relevant endothelial dysfunction copd objectives determine pgi2 expression altered lung disease protective endothelial dysfunction methods evaluated immunohistochemistry western blotting polymerase chain reaction human emphysema tissue compared normal tissue expression prostacyclin synthase pgi2s examined effects cigarette smoke extract cse aldehyde components eicosanoid expression primary human pulmonary microvascular endothelial cells finally used murine model pgi2s overexpression vitro studies determine pgi2 expression protective effects cigarette endothelial apoptosis measurements main results human emphysema lung tissue exhibited lower pgi2s expression pulmonary endothelium normal lung vitro studies demonstrated cse particular alphabeta unsaturated aldehyde acrolein suppressed pgi2s gene expression cse significantly induced upstream mediators cytosolic phospholipase a2 human pulmonary microvascular endothelial cells mice pgi2s overexpression exhibited endothelial apoptosis chronic smoke exposure vitro iloprost exhibited protective effects apoptosis conclusions pgi2 protective effects pulmonary vasculature acute chronic cigarette smoke exposure imbalance eicosanoid expression important endothelial dysfunction cell dependent smoking related copd associated lung specific smoke induced cox NUMBER lung specific cse induced copd associated